ClinicalTrials.Veeva

Menu

Health Effects of Oat Bioactives (Betaglucan) in Human

L

Lund University

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Effects of Oat and Oat Components on Cardiometabolic risk variables

Study type

Interventional

Funder types

Other

Identifiers

NCT05801653
Dnr. 2018/658 (del 4)

Details and patient eligibility

About

Aim of the study is to investigate health effects of oats and oat derived components, in human intervention studies, with the purpose to build new knowledge for development of cardiometabolic protective foods.

Full description

The overall goal is to increase the knowledge which can be used for the development of food products with anti-diabetic properties, with the purpose to facilitate healthier food choices for people. More specifically the primary purpose of this project is to evaluate effects in healthy humans on cardiometabolic test markers of oat and oat based product. The new knowledge will form a base for the development of oat based food products with added health values.

Enrollment

20 patients

Sex

All

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy adults BMI 18.5 - 28 Kg/m2 Non smokers Consuming a non-vegetarian diet that follows the Nordic diet recommendation.

Exclusion criteria

  • Fasting blood glucose concentration >6.1 mmol/l Known cardio-metabolic disease (e.g. diabetes, hypertension, metabolic syndrome).

Gastro-intestinal disorders such as IBS (irritable bowel syndrome) that can interfere with the study results, food allergies.

No antibiotics or probiotics should have been consumed within 4 weeks prior to and during the study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

20 participants in 4 patient groups, including a placebo group

Oat meal 1
Experimental group
Description:
The test portion is based on 30 gram available carbohydrates with added x amount oat betaglucan. Test portion consumed as a breakfast meal prior to determinations of test variables in the morning
Treatment:
Dietary Supplement: Effects of Oat and Oat Components on Cardiometabolic risk variables
Oat meal 2
Experimental group
Description:
The test portion is based on 30 gram available carbohydrates with added y amount of oat betaglucan. Test portion consumed as a breakfast meal prior to determinations of test variables in the morning
Treatment:
Dietary Supplement: Effects of Oat and Oat Components on Cardiometabolic risk variables
Oat meal 3
Experimental group
Description:
The test portion is based on 30 gram available carbohydrates with added z amount of oat betaglucan. Test portion consumed as a breakfast meal prior to determinations of test variables in the morning
Treatment:
Dietary Supplement: Effects of Oat and Oat Components on Cardiometabolic risk variables
Reference
Placebo Comparator group
Description:
The test portion is based on 30 gram available carbohydrates without added oat betaglucan. Test portion consumed as a breakfast meal prior to determinations of test variables in the morning
Treatment:
Dietary Supplement: Effects of Oat and Oat Components on Cardiometabolic risk variables

Trial contacts and locations

1

Loading...

Central trial contact

Mohammad Mukul Hossain; Anne Nilsson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems